US Food and Drug Administration Accelerated Approval Program for Nononcology Drug Indications Between 1992 and 2018
US Food and Drug Administration Accelerated Approval Program for Nononcology Drug Indications Between 1992 and 2018
Kenji Omae,Akira Onishi,E. Sahker,T. Furukawa
2022 · DOI: 10.1001/jamanetworkopen.2022.30973
JAMA Network Open · 50 Citations
Abstract
This cohort study evaluates how the US Food and Drug Administration (FDA) accelerated approval program has been used for nononcology drugs over a period of 26 years.